The biopharma industry has been relatively quiet in terms of mergers and acquisitions in recent years, but 2025 seems to…
Browsing: biopharma
Artificial intelligence is taking shape as a major revolution in biopharma, from drug discovery to clinical trials. The wheels of…
Dr. Laura Williams, Ardelyx’s Chief Patient Officer, is leading the charge in improving clinical trial diversity at the company. In…
With the proposed funding cuts to the National Institutes of Health by the Trump administration, the biopharma industry is bracing…
As leaders in the biomedical and health sciences industry in the United States, we understand the critical role that federal…
As the nation’s health secretary, Robert F. Kennedy Jr. has been a polarizing figure in the pharmaceutical and biotech industries.…
China’s Growing Influence in the Global Pharma Industry China’s presence in the global pharmaceutical landscape is rapidly expanding, with recent…
The recent confusion surrounding federal funding under the Trump administration has left many in the biotech and pharma industries uncertain…
